Search research articles
Contact Us
Filters
Showing results (161-170 of 525) with videos related to
Page
of 53
Sort By:
Molecular Cancer Research : MCR
|
December 10, 2017
Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia
Franz Josef Gassner, Maria Schubert, Stefan Rebhandl, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 28, 2004
Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors
Bernhard Holzner, Georg Kemmler, David Cella, et al.
Nucleic Acids Research
|
February 16, 2021
SAMHD1 restrains aberrant nucleotide insertions at repair junctions generated by DNA end joining
Ekaterina Akimova, Franz Josef Gassner, Maria Schubert, et al.
Journal of Clinical Medicine
|
July 13, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade
Florian Huemer, David Lang, Theresa Westphal, et al.
Wiener Klinische Wochenschrift
|
September 17, 2017
Improvement of quality of life and psychological distress after inpatient cancer rehabilitation : Results of a longitudinal observational study
David Riedl, Johannes M Giesinger, Lisa M Wintner, et al.
American Journal of Hematology
|
May 13, 2016
An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM)
Xavier Leleu, Evangelos Terpos, Ramón García Sanz, et al.
Anticancer Research
|
May 7, 2017
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study
Wolfgang Eisterer, Gudrun Piringer, Alexander DE Vries, et al.
Technology in Cancer Research & Treatment
|
January 8, 2026
Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria - a Large Single-Center Experience
Michael Leisch, Dominik Kiem, Christoph Grabmer, et al.
Cancer Research
|
September 9, 2010
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells
Sebastian W Hofbauer, Josefina D Piñón, Gabriele Brachtl, et al.
Leukemia & Lymphoma
|
December 31, 2014
VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions
Elisabeth Hinterseer, Olga Stiefel, Daniel Neureiter, et al.
Page
of 53
Search research articles
Search
Showing results (161-170 of 525) with videos related to
Sort By:
Page
of 53
Molecular Cancer Research : MCR
|
December 10, 2017
Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia
Franz Josef Gassner, Maria Schubert, Stefan Rebhandl, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 28, 2004
Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors
Bernhard Holzner, Georg Kemmler, David Cella, et al.
Nucleic Acids Research
|
February 16, 2021
SAMHD1 restrains aberrant nucleotide insertions at repair junctions generated by DNA end joining
Ekaterina Akimova, Franz Josef Gassner, Maria Schubert, et al.
Journal of Clinical Medicine
|
July 13, 2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade
Florian Huemer, David Lang, Theresa Westphal, et al.
Wiener Klinische Wochenschrift
|
September 17, 2017
Improvement of quality of life and psychological distress after inpatient cancer rehabilitation : Results of a longitudinal observational study
David Riedl, Johannes M Giesinger, Lisa M Wintner, et al.
American Journal of Hematology
|
May 13, 2016
An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM)
Xavier Leleu, Evangelos Terpos, Ramón García Sanz, et al.
Anticancer Research
|
May 7, 2017
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study
Wolfgang Eisterer, Gudrun Piringer, Alexander DE Vries, et al.
Technology in Cancer Research & Treatment
|
January 8, 2026
Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria - a Large Single-Center Experience
Michael Leisch, Dominik Kiem, Christoph Grabmer, et al.
Cancer Research
|
September 9, 2010
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells
Sebastian W Hofbauer, Josefina D Piñón, Gabriele Brachtl, et al.
Leukemia & Lymphoma
|
December 31, 2014
VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions
Elisabeth Hinterseer, Olga Stiefel, Daniel Neureiter, et al.
Page
of 53